---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "hJgkLUMpA1Ll1nN4FuI8jkDOWJP1803iHxglRNOobiCNRttfFJCoCH6QqA9ALjSjU3Q/+IM5vz0alYXbXaLPJ9oPCikqaiIpTeU8MfRPcUG1Q499pBuHzZGo8G1mIfJrME8XTP5lb7vgV1FmOVy20TDfLV8gON+EqFtjcqa67tACGy0/Y/sAeVsLGa4c9HOw7VGCwziRf4uXBo8WtcPJBoBb0DbvfKHmj2Iz0liQy7ABPDDs1shDkQFdL9xwIaYly1EDdiLq3QReL1O+0AGiUHOz6JJj7M8Y+jRONjS+H25y5Xgexte7RnqfhHa32ibe;sqt7G40IRifC0jSYVkgTcg=="
---

